System Biology Approach for Identification of New Targets and Biomarkers: I-Ming Wang, PhD | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

« The Role of Informatics in ADMA Pharmacogenetics: Boyd Steere, PhD

BIND Therapeutics and AstraZeneca: Collaboration on Nanomedicines Selectively of Drug Concentrations – Tumor vs Healthy Tissues »

System Biology Approach for Identification of New Targets and Biomarkers: I-Ming Wang, PhD

April 22, 2013 by 2012pharmaceutical

Reporter: Aviva Lev-Ari, PhD, RN

Systems Pharmacology – Pathways to Patient Response @ BioIT World, April 9-11, 2013, World Trade Center, Boston, MA

I-Ming Wang, PhD’s presentation at the conference is to be viewed at the link, below

http://www.chiresource.com/BIT-05-23/Presentations/NPC/Wang_I-Ming.pdf

Advertisements

Posted in Biomarkers & Medical Diagnostics, Computational Biology/Systems and Bioinformatics | 1 Comment

One Response

on April 22, 2013 at 5:01 PM | Reply larryhbern

This presentation is rich, and with a very good knowledge of the underlying pathogenetic alterations.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Google account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

%d bloggers like this: